share_log

藥明合聯:2024中期報告

WUXI XDC: Interim Report 2024

HKEX ·  Sep 26 17:18

Summary by Futu AI

藥明合聯生物技術有限公司(WUXI XDC)於2024年6月30日公布其半年度財務報告。報告顯示,公司在截至2024年6月30日的六個月內,收益達到人民幣1,665.2百萬元,同比增長67.6%;毛利為人民幣535.3百萬元,同比增長133.4%。公司擁有人應佔純利為人民幣488.2百萬元,同比大幅增長175.5%。此外,公司擁有人應佔經調整純利(非國際財務報告準則指標)為人民幣533.6百萬元,同比增長146.6%。公司於2023年11月成功完成全球發售並於聯交所主板上市,集資總額逾40億港元。董事會不建議就截至2024年6月30日止六個月派付任何中期股息。
藥明合聯生物技術有限公司(WUXI XDC)於2024年6月30日公布其半年度財務報告。報告顯示,公司在截至2024年6月30日的六個月內,收益達到人民幣1,665.2百萬元,同比增長67.6%;毛利為人民幣535.3百萬元,同比增長133.4%。公司擁有人應佔純利為人民幣488.2百萬元,同比大幅增長175.5%。此外,公司擁有人應佔經調整純利(非國際財務報告準則指標)為人民幣533.6百萬元,同比增長146.6%。公司於2023年11月成功完成全球發售並於聯交所主板上市,集資總額逾40億港元。董事會不建議就截至2024年6月30日止六個月派付任何中期股息。
WUXI XDC announced its half-year financial report on June 30, 2024. The report shows that the company's revenue reached 1,665.2 million RMB in the six months ending June 30, 2024, an increase of 67.6% year-on-year; gross profit was 535.3 million RMB, an increase of 133.4% year-on-year. The net profit attributable to owners of the company was 488.2 million RMB, a significant increase of 175.5% year-on-year. In addition, the adjusted net profit attributable to owners (non-IFRS indicators) was 533.6 million RMB, an increase of 146.6% year-on-year. The company successfully completed a global offering in November 2023 and was listed on the Main Board of the Stock Exchange of Hong Kong, raising over 4 billion HK dollars. The Board of Directors does not recommend paying any interim dividends for the six months ending June 30, 2024.
WUXI XDC announced its half-year financial report on June 30, 2024. The report shows that the company's revenue reached 1,665.2 million RMB in the six months ending June 30, 2024, an increase of 67.6% year-on-year; gross profit was 535.3 million RMB, an increase of 133.4% year-on-year. The net profit attributable to owners of the company was 488.2 million RMB, a significant increase of 175.5% year-on-year. In addition, the adjusted net profit attributable to owners (non-IFRS indicators) was 533.6 million RMB, an increase of 146.6% year-on-year. The company successfully completed a global offering in November 2023 and was listed on the Main Board of the Stock Exchange of Hong Kong, raising over 4 billion HK dollars. The Board of Directors does not recommend paying any interim dividends for the six months ending June 30, 2024.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.